Catheter-Related Bloodstream Infection Market Growth Is Accelerating As Industry Transformation Continues
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Catheter-Related Bloodstream Infection Market Expansion From $1.71 Billion In 2026 To $2.1 Billion In 2030
The market for catheter-related bloodstream infection solutions experienced robust expansion recently, projecting a rise from $1.62 billion in 2025 to $1.71 billion in 2026, reflecting a compound annual growth rate of 6.0%. Key factors driving this historical growth trajectory include a greater reliance on central venous catheters, an escalating prevalence of infections acquired within healthcare settings, the implementation of antibiotic lock therapy, the proliferation of intensive care units, and heightened clinical consciousness regarding catheter-related bloodstream infections.
The market for catheter-related bloodstream infections is poised for significant expansion in the upcoming years, projected to reach a value of $2.11 billion by 2030, driven by a compound annual growth rate of 5.3%. This anticipated growth throughout the forecast period stems from several key factors, including heightened investments in infection prevention strategies, an escalating need for effective antimicrobial resistance management, the broadening of hospital infection control initiatives, a greater uptake of combined therapeutic approaches, and advancements in diagnostic tool development. During this same period, prominent market trends are expected to include a more widespread utilization of sophisticated antimicrobial lock solutions, increased implementation of infection surveillance programs, a stronger emphasis on preventing hospital-acquired infections, the expanded application of combination antimicrobial treatments, and a more concentrated effort on early detection and timely intervention.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16646&type=smp
Catheter-Related Bloodstream Infection Market Expansion Supported By Key Demand Factors
The increasing incidence of infections acquired in hospital settings is anticipated to fuel the expansion of the market for catheter-related bloodstream infections. Infections contracted within healthcare facilities, often appearing 48 hours or more post-admission, stem from factors including the rise of resistant microbes, insufficient infection control practices, and patient vulnerabilities. Given their invasive nature and propensity for microbial growth, catheter-related bloodstream infections represent a substantial portion of these hospital-acquired infections, especially for individuals with inserted catheters. Illustrating this point, data from September 2025, sourced from the National Library of Medicine, indicates that in 2024, antimicrobial-resistant organisms constituted 6.6% of infections, with approximately one-third of healthcare-associated infections being linked to medical devices, and the occurrence of central line-associated bloodstream infections doubling to 0.4%. Consequently, the escalating rate of hospital-acquired infections is poised to stimulate market growth in the catheter-related bloodstream infection sector.
An upswing in spending on healthcare services is foreseen to be a significant catalyst for the expansion of the catheter-related bloodstream infection market. This refers to the aggregate financial investment in safeguarding, curing, and overseeing health issues by various entities. Such increased spending is largely a consequence of medical advancements, as novel diagnostic equipment, therapeutic interventions, and cutting-edge treatments frequently incur substantial costs, leading to a broader financial outlay in healthcare. Enhanced healthcare spending contributes to mitigating catheter-related bloodstream infections by allocating resources towards preventative strategies, professional development, surveillance mechanisms, and prompt medical care, thereby ultimately enhancing patient results and reducing long-term expenses. To illustrate, information released in December 2024 by the Centers for Medicare & Medicaid Services highlights that in 2023, healthcare spending in the United States rose by 7.5%, reaching $4.9 trillion, equating to approximately $14,570 per person. Therefore, the augmenting levels of healthcare expenditure are actively propelling the growth trajectory of the catheter-related bloodstream infection market.
Catheter-Related Bloodstream Infection Market Segment Analysis: What Are The Major Market Categories?
The catheter-related bloodstream infection market covered in this report is segmented –
1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents
2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneumonia), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginosa), Other Source Of Infection Or Causative Agents
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies
Subsegments:
1) By Antibiotic Lock Therapy: Catheter Lock Solutions (Antibiotic-based), Combination Antibiotic Lock Therapy
2) By Anti-Microbial Agents: Antibiotics, Antifungal Agents, Antiseptic Agents
Catheter-Related Bloodstream Infection Market Growth Trends Influencing Competitive Dynamics
Pioneering firms within the catheter-related bloodstream infection sector are actively creating novel catheter lock mechanisms aimed at bolstering infection control and elevating patient well-being; these lock solutions are liquids introduced into a catheter to safeguard against infections and preserve its unobstructed state between administrations. A prime illustration of this innovation is CorMedix Inc., a US-based biopharmaceutical entity dedicated to therapeutic product development and marketing, which secured crucial US Food and Drug Administration endorsement in November 2023 for DefenCath. This particular catheter lock solution, a synergistic blend of taurolidine and heparin, is now accessible for adult patients experiencing kidney failure and undergoing ongoing hemodialysis through a central venous catheter (CVC). The antimicrobial and antifungal formulation is engineered specifically to mitigate catheter-related bloodstream infections (CRBSIs), effectively integrating heparin’s anticoagulant benefits with taurolidine’s extensive antibacterial and antifungal efficacy.
Catheter-Related Bloodstream Infection Market Leading Companies Driving Competitive Growth
Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC
Access The Complete Catheter-Related Bloodstream Infection Market Report:
Catheter-Related Bloodstream Infection Market Largest Region By Revenue And Market Share
North Americawas the largest region in the catheter-related bloodstream infection market in 2025. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
